Daily Market Recap: August 18, 2025
Today’s session saw a broad advance in small- and mid-cap names, led by biotech and resource plays. After yesterday’s mixed performance, investors piled into lower-priced stocks, driving several tickers to triple-digit gains on heavy volume. Overall, market breadth skewed positive as catalysts ranging from clinical updates to listing clearances spurred buying interest.
Stock Performance Table
| Ticker | ATTN Price | Current Price | Volume | Price Change % |
|---|---|---|---|---|
| ASBP | 0.3422 | 0.5701 | 267,288,324 | +66.66% |
| PPCB | 2.7256 | 5.0900 | 36,510,024 | +86.83% |
| TPIC | 0.0582 | 0.1231 | 38,677,830 | +111.73% |
| BTAI | 4.5990 | 5.7697 | 17,851,869 | +25.46% |
| DAY | 63.0979 | 66.5500 | 6,860,001 | +5.50% |
| DHAI | 0.2362 | 0.3032 | 76,394,235 | +28.48% |
| SNGX | 2.5744 | 4.4900 | 110,993,124 | +74.48% |
| MB | 2.7315 | 6.1600 | 7,477,860 | +125.46% |
| SUUN | 1.8509 | 2.2900 | 1,149,619 | +23.76% |
| GDRX | 4.3140 | 5.2100 | 35,242,603 | +20.76% |
| WGRX | 0.5230 | 0.8442 | 50,775,488 | +61.41% |
| IPA | 2.0014 | 2.7499 | 6,879,885 | +37.39% |
| PSQH | 1.5606 | 1.8150 | 873,018 | +16.35% |
| ILLR | 0.3566 | 0.5425 | 9,926,405 | +52.16% |
| SMRT | 1.3160 | 1.5200 | 2,628,999 | +15.56% |
Market Trends and Analysis
Biotech-related tickers dominated today’s activity, benefiting from a steady flow of trial news and regulatory approvals. Volume was concentrated in sub-$1 names, where volatility remains elevated. Low-priced issues such as TPIC, ASBP and WGRX nearly doubled or more as speculative interest resurfaced. At the same time, select mid-caps—including BTAI and DAY—posted moderate gains on sector-specific developments.
From a sector perspective, health care led the advance while industrial and services names saw measured participation. DAY, a business-services provider, jumped 5.5% on robust volume following a positive earnings surprise. Resource-adjacent plays like MB attracted substantial inflows after announcing plans for a dual listing, prompting a 125% surge.
Liquidity conditions remained favorable, with total volume concentrated in high-beta names. The average volume across today’s top performers was roughly 60 million shares, highlighting sustained retail interest in smaller capitalizations.
Biotech Stocks by Markus Spiske
Highlights of Significant Movements
- MB (MasterBeef Group) vaulted 125.5% after its Nasdaq IPO lock-up expired and management confirmed a Frankfurt dual listing initiative.
- TPIC (TPI Composites) more than doubled, rising 111.7% on heavy trading as corporate restructuring rumors circulated.
- PPCB (PROPANC Biopharma) jumped 86.8% after the SEC cleared its S-1 registration, paving the way for a Nasdaq listing and funding of oncology trials.
- SNGX (Soligenix) rallied 74.5% on FDA exclusivity news for its lead asset, driving significant warrant exercises.
- ASBP (Aspire Biopharma) climbed 66.7% in response to SPAC merger completion and initiation of Phase 1 aspirin trials.
TL;DR
- Small-cap and biotech stocks led a broad market rally on August 18, 2025.
- MasterBeef Group (MB) soared 125% after dual-listing plans; TPI Composites (TPIC) doubled on restructuring speculation.
- PROPANC (PPCB) advanced nearly 87% with SEC clearance; Soligenix (SNGX) gained 74.5% on exclusivity news.
- Heavy volumes centered in sub-$1 names—ASBP, WGRX and ILLR among top performers.
- Industrial and service mid-caps saw moderate gains, while overall market breadth skewed positive.
